Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6426
Woodside Energy
WDS
$45.3B
| $2.05M | ﹤0.01% |
106,330
-97,814
| -48% | -$2.18M |
|
|
MRX
6427
PUT
Marex Group Limited Ordinary Shares
MRX
$4.98B
| $2.05M | ﹤0.01% |
+33,700
| New | +$1.85M |
|
6428
CALL
Americold
COLD
$4.27B
| $2.05M | ﹤0.01% |
130,500
| – | – |
|
6429
PUT
CVR Partners
UAN
$1.42B
| $2.05M | ﹤0.01% |
18,400
-1,500
| -8% | -$184K |
|
6430
PUT
United Natural Foods
UNFI
$2.67B
| $2.05M | ﹤0.01% |
44,900
+3,300
| +8% | +$163K |
|
6431
CALL
National Healthcare
NHC
$3.54B
| $2.05M | ﹤0.01% |
9,700
-2,900
| -23% | -$532K |
|
6432
PUT
Dentsply Sirona
XRAY
$2.01B
| $2.05M | ﹤0.01% |
193,200
-16,400
| -8% | -$179K |
|
6433
CALL
Acadia Pharmaceuticals
ACAD
$4.64B
| $2.05M | ﹤0.01% |
81,000
+61,000
| +305% | +$1.34M |
|
6434
PUT
Timken Company
TKR
$8.01B
| $2.05M | ﹤0.01% |
+14,100
| New | +$1.7M |
|
|
MTRA
6435
Invesco International Growth Focus ETF
MTRA
$132M
| $2.05M | ﹤0.01% |
+74,368
| New | +$1.94M |
|
6436
PUT
ASE Group
ASX
$96.2B
| $2.05M | ﹤0.01% |
45,400
+22,000
| +94% | +$739K |
|
6437
PUT
Kyndryl
KD
$3B
| $2.05M | ﹤0.01% |
181,100
+70,100
| +63% | +$874K |
|
6438
Simply Good Foods
SMPL
$869M
| $2.05M | ﹤0.01% |
+154,221
| New | +$1.9M |
|
6439
Neuropace
NPCE
$486M
| $2.05M | ﹤0.01% |
128,800
+41,516
| +48% | +$668K |
|
6440
CALL
Alcon
ALC
$32.7B
| $2.05M | ﹤0.01% |
30,500
+7,200
| +31% | +$504K |
|
6441
PGIM Short Duration Multi-Sector Bond ETF
PSDM
$229M
| $2.05M | ﹤0.01% |
40,192
+15,708
| +64% | +$803K |
|
6442
Ultrapar
UGP
$7.95B
| $2.05M | ﹤0.01% |
407,514
-510,516
| -56% | -$2.81M |
|
6443
PUT
Avery Dennison
AVY
$12.9B
| $2.05M | ﹤0.01% |
12,600
+7,900
| +168% | +$1.29M |
|
6444
T. Rowe Price Floating Rate ETF
TFLR
$791M
| $2.05M | ﹤0.01% |
40,577
+4,824
| +13% | +$245K |
|
6445
CALL
Mineralys Therapeutics
MLYS
$2.48B
| $2.05M | ﹤0.01% |
75,800
-13,700
| -15% | -$376K |
|
6446
PUT
Shoals Technologies Group
SHLS
$1.2B
| $2.04M | ﹤0.01% |
206,500
+54,600
| +36% | +$496K |
|
6447
Evertec
EVTC
$1.74B
| $2.04M | ﹤0.01% |
73,508
+31,394
| +75% | +$834K |
|
6448
CALL
Trex
TREX
$4.4B
| $2.04M | ﹤0.01% |
40,800
+4,900
| +14% | +$203K |
|
|
BEX
6449
Tradr 2X Long BE Daily ETF
BEX
$228M
| $2.04M | ﹤0.01% |
+34,134
| New | +$1.79M |
|
6450
PUT
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.5B
| $2.04M | ﹤0.01% |
8,400
| – | – |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.